(Q73906727)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1 reference

I Koivula

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Stén

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Leinonen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P H Mäkelä

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

281-290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Prospective study of the aetiology and outcome of pneumonia in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Immunization of elderly people with polyvalent pneumococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Protective Efficacy of Pneumococcal Polysaccharide Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Pneumococcal vaccine efficacy in selected populations in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

The Pneumococcal Vaccine After 15 Years of Use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Specific immunoglobulin-class antibody responses in the elderly before and after 14-valent pneumococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Risk factors for pneumonia in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Hospital study of adult community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Pneumonia in old age; active immunization against pneumonia with pneumonococcus polysaccharide; results of a six year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Accuracy of Gram's stain in identifying pneumococci in sputum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Measurement of antibody responses to pneumolysin--a promising method for the presumptive aetiological diagnosis of pneumococcal pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

The Etiology of Community-Acquired Pneumonia among Hospitalized Patients during a Chlamydia pneumoniae Epidemic in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Etiology of community-acquired pneumonia in out-patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

A cost-benefit analysis of immunization for pneumococcal pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Review of cost-benefit analyses of influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

Pneumococcal Vaccine in the Institutionalized Elderly: Review of Past and Recent Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900149-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(97)00149-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9382120%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference